Deutsche Bank's Takeaways From NUS's Analyst Day

Deutsche Bank has published a research report on Nu Skin Enterprises NUS after the company hosted an Analyst Day. In the report, Deutsche Bank writes "Fundamentals remain compelling with ageLOC transformation seeing solid repeat purchasers, Vitality trending well and launching in key markets and new detoxifying product launching next year. Long-term potential significant as company is yet to meaningfully tap large growth markets. While valuation is getting fuller and outsized ageLOC growth lapping, expectations are appropriate and balance sheet remains pristine with well incentivized and shareholder friendly management team." Deutsche Bank maintains its Buy rating and $35 price target. Nu Skin Enterprises closed Friday at $32.05.